Thomas Axelsson, born in 1959, has amongst other things been CEO of Stille and Artema, and is Chairman of the Board of amongst other things Dipylon Medical AB (formerly CMA Microdialysis AB) and Airsonett AB. Thomas is also a member of the Board of MedCap AB, listed on First North.Thomas Axelsson has completed his Phd in Copenhagen University at Denmark in 2014. He is an Aspirant at Stage 1 specialization in the sales. He is currently working in vitrolife as CEO, which is situated at Sweden.
He is intersted in Reproductive Medicine.